Trends in health care spending | Healthcare costs in the US | AMA

Oct 17, 2024

Health spending in the U.S. increased by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This growth rate is comparable to pre-pandemic rates (4.1% in 2019). Although government spending to manage the pandemic led to substantial increases in NHE, these expenditures significantly declined in 2021 while utilization of medical goods and services rebounded. By 2022, top-level patterns in health spending more closely reached that of the pre-pandemic period.

Overall, health spending was 17.3% of GDP in 2022, similar to pre-pandemic shares (17.5% in 2019) after an uptick in 2020 (19.5%) and 2021 (18.2%).

The AMA helps physicians build a better future for medicine, advocating in the courts and on the Hill to remove obstacles to patient care and confront today’s greatest health crises.

A new AMA Policy Research Perspective provides an in-depth look at U.S. health spending in 2022.

Policy Research Perspectives: National Health Expenditures, 2022: A Return to Pre-Pandemic Growth Rates As Spending on Physician Services Decelerates (PDF)

The United States spent $4,464.4 billion on health care in 2022.

This spending can be broken down into the following categories:

Although physician services is the second largest category of health spending, it generally grows more slowly than spending in the other large categories of personal health care. From 2012 to 2022, the average annual growth rate was 4.2% for physician services, 4.4% for hospital care and 4.7% for prescription drugs.

In 2022, physician spending grew only 2.6% due to slow growth in both prices and utilization.* This comes after higher growth in 2020 from spending on federal relief programs and in 2021 from the rebound in utilization of medical goods and services. Likewise, hospital care spending grew only 2.2% in 2022 due to slow growth in prices and declines in hospital days and discharges.* However, prescription drug spending grew 8.4%, driven by an acceleration in prescription drug prices and increased utilization of retail prescription drugs.*

The report discusses this breakdown in further detail and also assesses spending by source of funds (i.e., private health insurance, Medicare, Medicaid, etc.) and sponsors (i.e., federal government, households, private businesses, etc.).